Loading…

Less demand on stem cell marker-positive cancer cells may characterize metastasis of colon cancer

CD44 and CD133 are stem cell markers in colorectal cancer (CRC). CD44 has distinctive isoforms with different oncological properties like total CD44 (CD44T) and variant CD44 (CD44V). Clinical significance of such markers remains elusive. Sixty colon cancer were examined for CD44T/CD44V and CD133 at...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2023-04, Vol.18 (4), p.e0277395-e0277395
Main Authors: Kaida, Takeshi, Fujiyama, Yoshiki, Soeno, Takafumi, Yokota, Mitsuo, Nakamoto, Shuji, Goto, Takuya, Watanabe, Akiko, Okuno, Kota, Nie, Yusuke, Fujino, Shiori, Yokota, Kazuko, Harada, Hiroki, Tanaka, Yoko, Tanaka, Toshimichi, Yokoi, Keigo, Kojo, Ken, Miura, Hirohisa, Yamanashi, Takahiro, Sato, Takeo, Sasaki, Jiichiro, Sangai, Takafumi, Hiki, Naoki, Kumamoto, Yusuke, Naitoh, Takeshi, Yamashita, Keishi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:CD44 and CD133 are stem cell markers in colorectal cancer (CRC). CD44 has distinctive isoforms with different oncological properties like total CD44 (CD44T) and variant CD44 (CD44V). Clinical significance of such markers remains elusive. Sixty colon cancer were examined for CD44T/CD44V and CD133 at mRNA level in a quantitative PCR, and clarified for their association with clinicopathological factors. (1) Both CD44T and CD44V showed higher expression in primary colon tumors than in non-cancerous mucosas (p
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0277395